Skip to main content
main-content

Type 2 diabetes


Browse the latest news, expert commentary, and educational content on type 2 diabetes.


Highlights

05-12-2022 | Pathophysiology | News

Study shows potential for type 2 diabetes characteristics to guide management

Research published in Nature Medicine shows how the specific characteristics of people with type 2 diabetes could one day guide disease management.

04-29-2022 | ATTD 2022 | Conference coverage | News

Poor glucose control risks SARS-CoV-2 infection despite immunization in type 2 diabetes

Poor glycemic control is associated with an impaired immune response to vaccination against SARS-CoV-2 and an increased risk for breakthrough infections in people with type 2 diabetes, report researchers.

04-27-2022 | Tirzepatide | News

Tirzepatide reduces liver fat, improves time in range

The publication of two SURPASS-3 substudies in The Lancet Diabetes & Endocrinology reveals significant benefits of tirzepatide on liver and abdominal fat in people with type 2 diabetes, as well as on time in target glucose range.

More on type 2 diabetes

The SURPASS trials

Get the latest reporting, researcher interviews, and independent commentary on tirzepatide for type 2 diabetes.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox